Title : Efficacy and toxicity of 2 schedules of frontline rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone plus bortezomib in patients with B-cell lymphoma: a randomized phase 2 trial from the French Adult Lymphoma Study Group (GELA).

Pub. Date : 2009 Oct 1

PMID : 19593797






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 CONCLUSIONS: R-CHOP + bortezomib was an effective regimen and produced an 84% CR rate. Chromium DNA damage inducible transcript 3 Homo sapiens